Cramer Rosenthal McGlynn’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,117,408
Closed -$26.9M 212
2016
Q4
$26.9M Sell
1,117,408
-55,872
-5% -$1.1M 0.4% 96
2016
Q3
$20.3M Sell
1,173,280
-45,100
-4% -$691K 0.31% 108
2016
Q2
$16.1M Buy
1,218,380
+246,195
+25% +$3.5M 0.26% 127
2016
Q1
$14.8M Sell
972,185
-367,725
-27% -$5.93M 0.23% 134
2015
Q4
$33M Sell
1,339,910
-296,063
-18% -$7.76M 0.5% 88
2015
Q3
$45.3M Buy
1,635,973
+204,718
+14% +$6.88M 0.61% 70
2015
Q2
$52.7M Buy
+1,431,255
New +$53.8M 0.65% 61

Other funds holding DK

Cramer Rosenthal McGlynn's DK Position: Q1 2017 in Review

Cramer Rosenthal McGlynn sold out of Delek US (DK) in Q1 2017, closing a stake of 1,117,408 shares — an estimated $26.9M sold.

Cramer Rosenthal McGlynn first reported a position in DK in Q2 2015 and held it in 7 quarters. The position peaked at $52.7M in Q2 2015. 149 funds tracked by Wall St. Rank hold DK as of Q1 2017.

  • Cramer Rosenthal McGlynn reported no remaining Delek US position as of Q1 2017 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 1,117,408 Delek US shares in Q1 2017, an estimated $26.9M.
  • Cramer Rosenthal McGlynn first reported a position in Delek US in Q2 2015 and held it in 7 quarters.
  • Cramer Rosenthal McGlynn's Delek US position peaked at $52.7M in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Delek US as of Q1 2017.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2017, filed 12 May 2017.